PREPARATION, CHARACTERIZATION, AND ACTIVATION OF A HIGHLY PURIFIED FACTOR-XI - EVIDENCE THAT A HITHERTO UNRECOGNIZED PLASMA ACTIVITY PARTICIPATES IN INTERACTION OF FACTORS XI AND XII

被引：63

作者：

SCHIFFMAN, S

LEE, P

机构：

[1] UNIV SO CALIF, MED SCH, DEPT MED, 2025 ZONAL AVE, LOS ANGELES, CA 90033 USA

[2] UNIV SO CALIF, MED SCH, DEPT BIOCHEM, 2025 ZONAL AVE, LOS ANGELES, CA 90033 USA

来源：

关键词：

D O I：

10.1111/j.1365-2141.1974.tb06778.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：101 / 114

页数：14

共 22 条

[1] Andrews P, 1970, Methods Biochem Anal, V18, P1, DOI 10.1002/9780470110362.ch1
[2] IMMUNOLOGIC CHARACTERIZATION OF 12 FACTOR 8 INHIBITORS
FEINSTEIN, DI
RAPAPORT, SI
CHONG, MNY
[J]. BLOOD-THE JOURNAL OF HEMATOLOGY, 1969, 34 (01): : 85 - +
[3] GOLDSTEIN R, 1960, 7 P INT C INT SOC HA, P1006
[4] CONTACT ACTIVATION OF HAGEMAN FACTOR AND INTERACTION OF HAGEMAN FACTOR AND PLASMA THROMBOPLASTIN ANTECEDENT
HAANEN, C
MORSELT, G
SCHOENMAKERS, J
[J]. THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1967, 17 (3-4): : 307 - +
[5] SEPARATION OF PLASMA THROMBOPLASTIN ANTECEDENT FROM KALLIKREIN BY PLLASMA ALPHA-L-MACROGLOBULIN, KALLIKREIN INHIBITOR
HARPEL, PC
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1971, 50 (10) : 2084 - &
[6] RELATION OF FLETCHER-FACTOR TO FACTOR-XI AND FACTOR-XII
HATHAWAY, WE
ALSEVER, J
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 1970, 18 (02) : 161 - &
[7] HJOST P, 1955, J LAB CLIN MED, V46, P89
[8] KERWIN DM, 1967, THROMB DIATH HAEMOST, V17, P247
[9] INHIBITION OF HAGEMAN FACTOR ACTIVATION
NOSSEL, HL
RUBIN, H
DRILLINGS, M
HSIEH, R
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1968, 47 (05) : 1172 - +
[10] NOSSEL HL, 1964, CONTACT PHASE BLOOD